Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;6(11):3006-3014.
doi: 10.1002/hep4.2070. Epub 2022 Sep 9.

High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module

Affiliations

High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module

Cristina Rigamonti et al. Hepatol Commun. 2022 Nov.

Abstract

Spleen stiffness measurement (SSM) by vibration-controlled transient elastography (VCTE) is a noninvasive technique for estimating portal hypertension in patients with chronic liver disease (CLD), with its reproducibility yet to be established and its feasibility still unknown beyond CLD. We have studied 420 participants from two tertiary referral centers for liver diseases (Novara, Milan): 297 patients with CLD (32% with cirrhosis) of different etiology (Group A), 63 Philadelphia-negative myeloproliferative neoplasms (Group B), and 60 heathy volunteers (Group C). All underwent SSM by VCTE with a spleen-dedicated module (SSM@100 Hz) and liver stiffness measurement (LSM), blindly performed by 2 different operators. In total, 1680 VCTE examinations for SSM were performed (1000 in Novara, 680 in Milan), with an overall 3.2% failure rate. Median SSM was 26.5 kPa (interquartile range [IQR] 20.0-42.3) in Group A, 26.3 kPa (IQR 22.3-33.6) in Group B, and 16.1 kPa (IQR 14.6-18.7) in Group C. In Group A, the median LSM was 6.8 kPa (IQR 4.9-11.3) in Novara and 8.3 kPa (IQR 7.1-10.8) in Milan, the proportion of patients with cirrhosis being 34% in Novara and 31% in Milan. The Group A interobserver agreement ICC was 0.90 (0.88-0.92), significantly lower in the absence of splenomegaly (ICC 0.87 vs. 0.91) and in absence of cirrhosis (ICC 0.84 vs. 0.90); overweight slightly, but not significantly reduced the interobserveragreement. The intra-observer agreement ICC ranged from 0.91 to 0.96 for the four operators. The Group B interobserver agreement ICC was 0.90 (0.83-0.94). In conclusion, SSM measured by the new spleen-dedicated VCTE module is a feasible, reliable, and highly reproducible tool in patients with CLD and hematological disorders, and in healthy volunteers.

PubMed Disclaimer

Conflict of interest statement

AP consults for and received grants from Sanofi, and consults for Incyte, Pfizer, and Novartis. MFD is on the speakers' bureau of, and received grants from, Kedrion. She advises Novartis and Gilead.

Figures

FIGURE 1
FIGURE 1
Bland‐Altmann plot. The solid line represents the mean of the difference of ratings by the two operators. The dotted lines define the limits of agreement, mean of the difference (2 SD)
FIGURE 2
FIGURE 2
Interobserver agreement (A,D) and intra‐observer agreement (B,C,E,F) on spleen stiffness measurement in patients with chronic liver disease (CLD). (A–C) Patients with CLD from Novara. (D–F) Patients with CLD from Milan

Comment in

References

    1. Vergniol J, Foucher J, Terrebonne E, Bernard PH, le Bail B, Merrouche W, et al. Noninvasive tests for fibrosis and liver stiffness predict 5‐year outcomes of patients with chronic hepatitis C. Gastroenterology. 2011;140:1970–9. - PubMed
    1. Fraquelli M, Giunta M, Pozzi R, Rigamonti C, Della Valle S, Massironi S, et al. Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis. J Viral Hepat. 2014;21:90–8. - PubMed
    1. Colecchia A, Montrone L, Scaioli E, Bacchi‐Reggiani ML, Colli A, Casazza G, et al. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV‐related cirrhosis. Gastroenterology. 2012;143:646–54. - PubMed
    1. Colecchia A, Colli A, Casazza G, Mandolesi D, Schiumerini R, Reggiani LB, et al. Spleen stiffness measurement can predict clinical complications in compensated HCV‐related cirrhosis: a prospective study. J Hepatol. 2014;60:1158–64. - PubMed
    1. Colecchia A, Marasco G, Taddia M, Montrone L, Eusebi LH, Mandolesi D, et al. Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature. Eur J Gastroenterol Hepatol. 2015;27:992–1001. - PubMed

MeSH terms